Chinook therapeutics stock price
Web2 days ago · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, … WebApr 13, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and ...
Chinook therapeutics stock price
Did you know?
WebMar 31, 2024 · Free-Float. 94,6%. More Financials. Company. Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing precision medicines for kidney diseases. Its lead product candidate is atrasentan, a potent and selective endothelin A receptor (ET A receptor), … WebChinook Therapeutics, Inc. (KDNY) Stock Historical Prices & Data - Yahoo Finance U.S. markets close in 4 hours 53 minutes S&P 500 -20.59(-0.50%) Dow 30 33,471.03 -14.26(-0.04%) Nasdaq...
WebApr 13, 2024 · Chinook Therapeutics, Inc. SEATTLE, April 13, 2024 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical … WebMar 23, 2024 · The latest price target for . Chinook Therapeutics (NASDAQ: KDNY) was reported by Piper Sandler on March 6, 2024.The analyst firm set a price target for $41.00 expecting KDNY to rise to within 12 ...
WebChinook Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. WebApr 14, 2024 · Chinook Therapeutics, Inc. ( NASDAQ:KDNY – Get Rating )’s share price was up 3.2% on Wednesday . The stock traded as high as $21.08 and last traded at $21.04. Approximately 109,125 shares were traded during trading, a decline of 80% from the average daily volume of 540,593 shares. The stock had previously closed at $20.38.
WebFeb 21, 2024 · What is the target price for Chinook Therapeutics (KDNY) stock? A. The latest price target for Chinook Therapeutics ( NASDAQ: KDNY) was reported by Oppenheimer on Tuesday, February 21, 2024. The ...
WebChinook Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time KDNY stock price. prime weapons that aren\u0027t mastery lockedWebView the latest Chinook Therapeutics Inc. (KDNY) stock price, news, historical charts, analyst ratings and financial information from WSJ. prime weapons for mastery rank 5WebChinook Therapeutics (KDNY) Stock Price & Analysis 433 Followers Portfolio KDNY Stock Chart & Stats Advanced Chart > Day’s Range $0 - $0 52-Week Range $12.41 - $27.44 Previous Close $21.53 Volume 136.19K Average Volume (3M) 534.61K Market Cap $1.45B Enterprise Value $1.08B Total Cash (Recent Filing) $378.32M Total Debt … prime weaponsWebStock Price Forecast The 12 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 35.00, with a high estimate of 51.00 and a low estimate of 30.00. prime weaponryWebChinook Therapeutics (KDNY) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Support: 888-992-3836 Home NewsWire Subscriptions play sonic spinball onlineWeb17 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Chinook Therapeutics (KDNY) prime weapons for mastery rank 7WebJul 13, 2024 · Shares of Chinook Therapeutics have increased 15.02% over the past quarter, and have gained 21.82% in the last year. In comparison, the S&P 500 has only moved -12.73% and -11.46%, respectively ... prime weapons for mastery rank 6